Page 8 - These Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigen...

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations. Working against this dynamic market are the f...

4.3.6 The Next Five Years 5. Cell Based Assays Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance Cancer Genetics to Acquire Organoid Startup Stemonix Curi Bio Acquires Artificial Intelligence Firm Dana Solutions CRISPR Screens Uncover Novel Cancer Therapy Targets ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam New Transcriptomics Assay Facilitates Compound Screens Carta Biosciences Betting on Gene Interaction Mappi...

Will Personalized Companion Diagnostics become the norm for diagnostics? Companion Diagnostics are poised to revolutionize the diagnostics industry. The market is finally moving out of the lab and into the clinic. Oncology, especially immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find out the latest outlook for this important market. Learn all about how diagnostic players are jockeying for position with their pha...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments Biohacking trend supports self testing. PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self...